Fluoxetine in the treatment of borderline and schizotypal personality disorders

Paul J. Markovitz, Joseph R. Calabrese, S. Charles Schulz, Herbert Y. Meltzer

Research output: Contribution to journalArticlepeer-review

188 Scopus citations


Twenty-two patients meeting the criteria for borderline or schizotypal personality disorder or both participated in a prospective, nonblind 12-week trial of fluoxetine. There were significant reductions in self-injury and in scores on the Hopkins Symptom Checklist regardless of diagnosis. The results suggest that controlled trials of fluoxetine and investigations of the serotonergic system in these disorders would be useful.

Original languageEnglish (US)
Pages (from-to)1064-1067
Number of pages4
JournalAmerican Journal of Psychiatry
Issue number8
StatePublished - Jan 1 1991


Dive into the research topics of 'Fluoxetine in the treatment of borderline and schizotypal personality disorders'. Together they form a unique fingerprint.

Cite this